Buscar
Mostrando ítems 1-10 de 174
Usefulness of discriminability and response bias indices for the evaluation of recognition memory in mild cognitive impairment and Alzheimer disease
(Dementia and Geriatric Cognitive Disorders, 2018)
Neuropsychological profile of Alzheimer's disease based on amyloid biomarker findings results from a South American cohort.
(Corporación Universidad de la Costa, 2021)
Cognitive changes in patients with epilepsy identified through the MoCA test during neurology outpatient consultation
(Corporación Universidad de la Costa, 2021)
Reversible cognitive impairment and parkinsonism with leukoencephalopathy due to cranial dural arteriovenous fistula
(Corporación Universidad de la CostaColombia, 2022)
Reversible cognitive impairment and parkinsonism with leukoencephalopathy due to cranial dural arteriovenous fistulaDeterioro cognitivo reversible y parkinsonismo con leucoencefalopatía por fístula arteriovenosa dural craneal
(Corporación Universidad de la CostaBarranquilla, Colombia, 2023)
Utility of a screening test (MoCa) to predict amyloid physiopathology in mild cognitive impairmentUtilidad de un test de screening (MoCa) para predecir fisiopatología amiloide en deterioro cognitivo leve
(Corporación Universidad de la CostaColombia, 2023)
Batería neuropsicológica conjunto de datos uniformes (UDS) para la evaluación de la enfermedad de Alzheimer y deterioro cognitivo leve: una revisión sistemática.Neuropsychological battery uniform data set (UDS) for the evaluation of Alzheimer's disease and mild cognitive impairment: a systematic review.
(Revista Ecuatoriana de Neurología, 2019)
Computational basis of decision-making impairment in multiple sclerosis
(SAGE Publications LtdUnited Kingdom, 2022)